Main Findings
To the best of our knowledge, this is the largest multi-centre Asian
population randomised controlled trial undertaken to evaluate the safety
of the DBC as well as the efficacy of the DBC compared to the vaginal
prostaglandin. Our findings show that the number of adverse events in
hyperstimulation and the use of entonox were significantly less in the
women allocated to the DBC group. Our study also showed similar labour
outcomes in both groups with regards to recourse to caesarean
deliveries. Average time to eventual delivery in both groups was
similar.